✦ LIBER ✦

Podoplanin is a useful marker for identifying mesothelioma in malignant effusions

✍ Scribed by Atef Hanna; Yijun Pang; Carlos W. M. Bedrossian; Annika Dejmek; Claire W. Michael

Book ID: 102141870
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 268 KB
Volume: 38
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.21340

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ferritin levels in malignant effusions:

Ferritin levels in malignant effusions: a useful marker?

✍ Paydaş, Semra; Sargin, Özoĝul; Özbek, Süleyman; Gürbüz, Elif 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 124 KB

Is Serum Thioredoxin-1 a Useful Clinical

Is Serum Thioredoxin-1 a Useful Clinical Marker for Malignant Pleural Mesothelioma?

✍ Maeda, Risa; Tabata, Chiharu; Tabata, Rie; Eguchi, Ryoji; Fujimori, Yoshihiro; N 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 183 KB

Podoplanin is a useful diagnostic marker

Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver

✍ Fujii, Takahiko; Zen, Yoh; Sato, Yasunori; Sasaki, Motoko; Enomae, Mio; Minato, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

IS GALECTIN-3 ANTIBODY A USEFUL MARKER I

IS GALECTIN-3 ANTIBODY A USEFUL MARKER IN THE DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA?

✍ Mlika, Mona; Ayadi-Kaddour, Aida; Ksantini, Meriem; Bouraoui, Saadia; Mzabi, Sab 📂 Article 📅 2013 🏛 Taylor and Francis Group 🌐 English ⚖ 525 KB

Tumor markers determination (Cyfra21-1 a

Tumor markers determination (Cyfra21-1 and CEA) is a useful approach for differential diagnosis in malignant pleural effusions and mesothelioma

✍ Felletti, R.E; Paganuzzi, M; Filiberti, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 233 KB

The use of CDKN2A deletion as a diagnost

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

✍ Illei, Peter B. ;Ladanyi, Marc ;Rusch, Valerie W. ;Zakowski, Maureen F. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

## Background: The distinction between benign reactive mesothelial cells and malignant mesothelial cells in serous effusions is difficult and has an unusually high false negative rate. unfortunately, there are no generally accepted markers to distinguish between benign reactive and malignant mesoth